Alexis Vallée-Bélisle, along with Nanogenecs Diagnostics, received the Prix Solution e-santé recherche clinique 2019 for the invention of a blood test procedure at home.

MONTREAL, November 18, 2019. On November 7th, the 1st IT Awards Gala in Health and Social Services was held. During the evening, recognition awards were given to the initiators of innovative technology projects that will improve the efficiency of the Quebec Health System. Alexis Vallée-Bélisle, professor in the Department of Chemistry at the Université de Montréal and holder of the Canada Research Chair in Bioengineering and Bionanotechnology, received the 2019 e-Health Research Award for the home blood test solution that he is developing in partnership with the Montreal-based company Nanogenecs Diagnostics.

This project, carried out in collaboration with Dr. Vincent De Guire, Hôpital Maisonneuve-Rosemont and Biron Group Santé, will ensure better monitoring of chronic diseases.

The Alexis Vallée-Bélisle project had already received a $ 700,000 INNOV grant from the Natural Sciences and Engineering Research Council of Canada and another $ 240,000 from the Ministry of the Economy and Innovation of Quebec. Commercialization is targeted by 2022.

The e-Health Clinical Research Solution Award "honors a healthcare professional, as well as a team, a digital health company or a qualified medical device provider that has developed the most innovative technology-based health solution ".

“We are thrilled to receive the recognition from the Quebec Ministry of Health and Social Services,” said Nancy Schoenbrunner, CEO of Nanogenecs. “Nanogenecs believes that safe and regular monitoring of blood-based biomarkers from the comfort of home will help give patients control over their health. Through commercialization of this technology, we are making the future of healthcare more sustainable for everyone.”

About Nanogenecs

Nanogenecs is an early-stage in vitro diagnostic (IVD) company whose vision is to help patients with chronic diseases better manage their conditions. Nanogenecs is building a convenient and inexpensive portable medical diagnostic platform that measures a patient’s blood biomarkers in minutes. Test results will be integrated with the electronic medical records and remote care plans from the patient’s health care providers to promote proactive care. Nanogenecs’ breakthrough technology of electrochemical DNA nanosensors was invented by Dr. Alexis Vallee-Belisle. Nanogenecs was co-founded by Dr. Alexis Vallee-Belisle and is headquartered in Montreal with offices in Boston.

  • Nanogenecs


Université de Montréal

2900 Edouard Montpetit Blvd, Montreal, QC H3T 1J4